MRI隨訪在經(jīng)導管灌注治療非創(chuàng)傷性股骨頭缺血性壞死療效評估中的價值
發(fā)布時間:2018-04-21 16:14
本文選題:股骨頭 + 壞死; 參考:《臨床放射學雜志》2016年04期
【摘要】:目的探討MRI隨訪在經(jīng)導管動脈灌注(TAI)治療非創(chuàng)傷性股骨頭缺血性壞死(ANFH)療效評估中的價值。方法對22例(30髖)經(jīng)臨床和影像學檢查確診的非創(chuàng)傷性ANFH患者采用TAI治療,并比較治療前后臨床癥狀、髖關節(jié)功能及MRI影像改變。隨訪觀察9~36個月。按ARCO分期,0期1髖;Ⅰ期6髖;Ⅱ期20髖;Ⅲa期3髖。結果 TAI術后,0期+Ⅰ期患者髖關節(jié)功能評分由術前平均(82.7±2.48)分增至術后平均(99.98±3.45)分;Ⅱ期患者髖關節(jié)功能評分由術前平均(76.9±3.23)分增至術后平均(95.07±3.68)分;Ⅲa期患者髖關節(jié)功能評分由術前平均(69.8±1.22)分增至術后平均(90.09±3.17)分。差異均有顯著性統(tǒng)計學意義(P0.05)。MRI隨訪發(fā)現(xiàn)19髖(63.3%)有不同程度好轉,股骨頭壞死區(qū)病灶穩(wěn)定,見增生、硬化及囊變縮小,骨髓水腫范圍變小,髖關節(jié)積液減少;2髖(6.7%)病變基本保持不變;9髖(30%)病變加重,表現(xiàn)為骨髓水腫范圍增大、髖關節(jié)積液增多,但在繼續(xù)隨訪中病變好轉。結論非創(chuàng)傷性ANFH患者TAI術后MRI隨訪有一定的價值,但需結合患者的臨床及其他影像資料才是科學的隨訪措施。
[Abstract]:Objective to evaluate the value of MRI follow-up in the treatment of nontraumatic avascular necrosis of femoral head (ANFH) by transcatheter arterial infusion (TAI). Methods 22 patients with nontraumatic ANFH diagnosed by clinical and imaging examinations were treated with TAI. The changes of clinical symptoms, hip function and MRI images before and after treatment were compared. The patients were followed up for 9 ~ 36 months. There were 1 hip in stage 0 according to ARCO stage, 6 hips in stage 鈪,
本文編號:1783161
本文鏈接:http://sikaile.net/huliyixuelunwen/1783161.html
最近更新
教材專著